Enalapril/Carvedilol for Prevention of Chemotherapy-Induced Heart Failure An End to the Problem
I read with great interest the article by Bosch et al. (1) looking at enalapril and carvedilol for prevention of chemotherapy-induced left ventricular systolic dysfunction (LVSD).
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Chemotherapy | Coreg | Enalapril | Heart | Heart Failure